reports
Sotera Health Reports First-Quarter 2024 Results
Sotera Health Reports First-Quarter 2024 Results Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in Q1 2023Q1 2024 Adjusted EBITDA(1) increased 13.7% to $112 million, compared to Q1 2023Q1 2024 Adjusted EPS(1) of $0.13 compared to Adjusted EPS of $0.13 in Q1 2023Company reaffirms 2024 outlook CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of missi...
Fenix Outdoor: Q1 report Fenix Outdoor International AG
Fenix Outdoor: Q1 report Fenix Outdoor International AG FENIX OUTDOOR INTERNATIONAL AGInterim condensed consolidated financial statements for the period ended 31 March 2024 First quarter 2024-01-01 – 2024-03-31 The total income of the Group was TEUR 168,676 (TEUR: 181,860), a decrease of 7.2%.The EBITDA of the Group was TEUR 27,212 (TEUR: 31,236).The operating profit of the Group was TEUR 12,782 (TEUR: 17,093).The profit before tax of the Group was TEUR 11,363 (TEUR: 16,302).The profit after tax of the Group was TEUR 6,910 (TEUR: 10,570).Earnings per share amounted to EUR 0.51 (EUR: 0.79)...
Fenix Outdoor: Kvartal 1 Fenix Outdoor International AG
Fenix Outdoor: Kvartal 1 Fenix Outdoor International AG Delårsrapport2024-01-01 – 2024-03-31 Första kvartalet 2024-01-01 – 2024-03-31 Koncernens rörelseintäkter uppgick till TEUR 168 676 (TEUR 181 860), En minskning med 7,2%Koncernens EBITDA uppgick till TEUR 27 212 (TEUR 31 236).Koncernens rörelseresultat uppgick till TEUR 12 782 (TEUR 17 093).Koncernens resultat före skatt uppgick till TEUR 11 363 (TEUR 16 302).Koncernens resultat efter skatt uppgick till TEUR 6 910 (TEUR 10 570).Resultat per aktie uppgick till EUR 0,51 (EUR 0,79). Händelser efter rapportperiodens slut Det har inte in...
Agios Reports Business Highlights and First Quarter 2024 Financial Res...
Agios Reports Business Highlights and First Quarter 2024 Financial Results – Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 – – Announced Positive Results from the Phase 3 ENERGIZE Study of Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia in January – – Phase 3 Readouts from Mitapivat RISE UP Study in Sickle Cell Disease, ACTIVATE-KIDS and ACTIVATE KIDS-T in Pediatric PK Deficiency, All Expected by End of 2025 – – PYRUKYND® (Mitapivat) Net Revenue of $...
OneWater Marine Inc. Announces Fiscal Second Quarter 2024 Results
OneWater Marine Inc. Announces Fiscal Second Quarter 2024 Results Maintaining previously issued fiscal full year 2024 outlook Fiscal Second Quarter 2024 Highlights Revenue decreased 7% to $488 millionSame-store sales decreased 5% for the quarter; average annual increase of 4% over last two yearsGross profit margin of 24.6%GAAP net loss of $(5) million, or $(0.27) per diluted share and adjusted diluted earnings per share1 of $0.67Adjusted EBITDA1 was $28 million BUFORD, Ga., May 02, 2024 (GLOBE NEWSWIRE) -- OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) t...
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Bever...
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage XMG Cannabis Brand Releases Latest Innovations with XMG Zero and XMG+ Beverages Now Available Across Canada TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced a bold new range of cannabis-infused beverages from , under two of its sub-brands: XMG Zero and XMG Plus (“XMG+”). XMG Zero, an extension of XMG’s original core line, now offers two new THC beverages: Cream Soda Zero and Orange Soda ...
Malibu Boats, Inc. Announces Third Quarter Fiscal 2024 Results
Malibu Boats, Inc. Announces Third Quarter Fiscal 2024 Results LOUDON, Tenn., May 02, 2024 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the third quarter ended March 31, 2024. Third Quarter Fiscal 2024 Highlights Compared to Third Quarter Fiscal 2023: Net sales decreased 45.8% to $203.4 millionUnit volume decreased 51.9% to 1,269 unitsGross profit decreased 59.1% to $40.3 millionGAAP net income decreased 226.8% to a net loss of $67.8 million, inclusive of goodwill and other intangible asset impairment charges of $88.4 million incur...
Lantheus Reports First Quarter 2024 Financial Results
Lantheus Reports First Quarter 2024 Financial Results First Quarter 2024 Worldwide revenue of $370.0 million, an increase of 23.0% from first quarter 2023 GAAP fully diluted net income per share of $1.87, compared to GAAP fully diluted net loss per share of $0.04 in first quarter 2023. Adjusted fully diluted net income per share of $1.69 compared to adjusted fully diluted net income per share of $1.47 in the first quarter 2023The Company increases full year 2024 net revenue and earnings guidance and provides guidance for the second quarter 2024 BEDFORD, Mass., May 02, 2024 (GLOBE NE...
DAVIDsTEA Reports Fourth Quarter and Full Year Fiscal 2023 Financial R...
DAVIDsTEA Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results Fiscal 2023 Sales of $60.6 millionNet loss of $13.8 millionAdjusted EBITDA of negative $5.4 millionCash position of $12.6 millionCompany enters into non-binding term sheet for revolving line of credit of up to $12.0 million Q4 Fiscal 2023 Sales of $24.4 millionNet loss of $3.9 millionAdjusted EBITDA of $0.5 million MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announced today its fo...
Les Thés DAVIDsTEA publient leurs résultats financiers du quatrième tr...
Les Thés DAVIDsTEA publient leurs résultats financiers du quatrième trimestre et de l’exercice 2023 Exercice financier 2023 Ventes de 60,6 M$Perte nette de 13,8 M$BAIIA ajusté d’une somme négative de 5,4 M$Trésorerie de 12,6 M$La Société conclut un accord de modalités de prêt non contraignant pour une ligne de crédit renouvelable d’un montant maximum de 12,0 M$ T4 2023 Ventes de 24,4 M$Perte nette de 3,9 M$BAIIA ajusté de 0,5 M$ MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Les Thés DAVIDsTEA inc. (TSXV : DTEA) (« DAVIDsTEA » ou la « Société »), l’u...
Aya Gold & Silver Announces At-Depth Drill Results at Zgounder Provide...
Aya Gold & Silver Announces At-Depth Drill Results at Zgounder Provides Notice of Q1-2024 Results and Conference Call MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce high-grade silver drill results from its at-depth drill exploration program at the Zgounder Silver Mine in the Kingdom of Morocco. Key Highlights (all intersections are in core lengths) In the Central Zone from the 1,950m level: hole ZG-SF-24-107 intercepted 1,459 grams per tonne (“g/t”) silver (“Ag”) over 5.5 m...
Aya Or & Argent annonce des résultats de forage en profondeur à Zgound...
Aya Or & Argent annonce des résultats de forage en profondeur à Zgounder ainsi que la date de la conférence téléphonique sur les résultats du T1-2024 MONTRÉAL, 02 mai 2024 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer des résultats de forage à haute teneur en argent dans le cadre de son programme de forage d’exploration en profondeur à la mine d’argent Zgounder dans le Royaume du Maroc. Principaux faits saillants (toutes les intersections sont en longueur dans l’axe de forage) Dans la zone Centrale, à ...
Perspective Therapeutics to Provide Recent Business Highlights and Rep...
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that it will report its first quarter 2024 financial results and provide a business update on Wednesday, May 15, 2024 before market open. The press release will be available on the newsroom section of the Company’s website at . About Perspective Therapeutics, Inc.Perspective Therapeu...
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M o...
BridgeBio launches BridgeBio Oncology Therapeutics (BBOT) with $200M of private external capital to accelerate the development of its novel precision oncology pipeline The oversubscribed financing was led by Cormorant Asset Management and co-led by Omega Funds with participation from affiliates of Deerfield Management, GV (Google Ventures), EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital (a Citadel company), Aisling Capital, Casdin Capital, and Longwood FundThis capital raise provides BBOT with runway to achieve significant clinical inflection points over the next 1...
Treasury Metals and Blackwolf to Create New Growth-Focused North Ameri...
Treasury Metals and Blackwolf to Create New Growth-Focused North American Gold Platform TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Treasury Metals Inc. (TSX: TML; OTCQX: TSRMF) (“Treasury” or “TML”) and Blackwolf Copper and Gold Ltd. (TSXV:BWCG; OTCQB: BWCGF) (“Blackwolf” or “BWCG”) are pleased to announce that they have entered into a definitive arrangement agreement dated May 1, 2024 (the “Agreement”) to combine the two companies to advance the Goliath Gold Complex Project (“GGC Project”) in Ontario towards production with a strengthened leadership, balance sheet and capital markets team...
Standard Uranium Announces Davidson River Drill Program Private Placem...
Standard Uranium Announces Davidson River Drill Program Private Placement for Up to C$3.0 Million & Share Consolidation VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) has determined, given the current strength in the global uranium sector, and uranium’s increasing importance as a green energy source, the timing is right to return to drill its flagship Davidson River project (the “Project”). To advance the Project, the board of directors has resolved to proceed with...
Editas Medicine Announces First Quarter 2024 Results Conference Call a...
Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET to discuss results for the first quarter 2024 and to provide a corporate update. To access the conference call: U.S. callers should dial and international callers should dial approximately five minutes before the call begins.Participants should ask to be c...
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will deliver a corporate presentation at the Aegis Virtual Conference on May 7, 2024 at 9:00 am ET. Dr. Mor’s presentation will be webcast live. The registration link to access the live presentation is included below and is also available ...
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9...
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 Conference Call Scheduled for May 9, 2024, at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today announced that it will report first quarter 2024 financial results on May 9, 2024, after the U.S. financial markets close. ADMA’s management team will host a live conference call and audio webca...
Plug Continues to Expand Cryogenic Sales with Multiple Customer Agreem...
Plug Continues to Expand Cryogenic Sales with Multiple Customer Agreements and International Expansion Agreements expand Plug’s reach in cryogenic equipment portfolio across sectors International expansion of cryogenic equipment services with certification of liquid hydrogen storage tanks and transport trailers in Korea LATHAM, N.Y., May 02, 2024 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, announced that it has been awarded contracts to supply cryogenic equipment to a multinational indust...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.